Rates of antifungal resistance among Spanish clinical isolates of Cryptococcus neoformans var. neoformans

Journal of Antimicrobial Chemotherapy

Volumn 56, Issue 6, 2005, Pages 1144-1147

  Perkins, Alexander ^a   Gomez Lopez, Alicia ^a   Mellado, Emilia ^a   Rodriguez Tudela, Juan L ^a   Cuenca Estrella, Manuel ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

EUCAST; Fluconazole resistance; Surveillance programmes

Indexed keywords

AMPHOTERICIN B; FLUCYTOSINE; ITRACONAZOLE; RAVUCONAZOLE; VORICONAZOLE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIFUNGAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CROSS RESISTANCE; CRYPTOCOCCUS NEOFORMANS; FUNGUS ISOLATION; HEALTH PROGRAM; HEALTH SURVEY; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN;

ANTIFUNGAL AGENTS; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; DRUG RESISTANCE, FUNGAL; HOSPITALS; HUMANS; MICROBIAL SENSITIVITY TESTS; SPAIN;

EID: 29444436494     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dki393     Document Type: Article

References (14)

1. Brandt ME, Pfaller MA, Hajjeh RA et al. Trends in antifungal drug susceptibility of Cryptococcus neoformans isolates in the United States: 1992 to 1994 and 1996 to 1998. Antimicrob Agents Chemother 2001; 45: 3065-9.
2. Venkateswarlu K, Taylor M, Manning NJ at al. Fluconazole tolerance in clinical isolates of Cryptococcus neoformans. Antimicrob Agents Chemother 1997; 41: 748-51.
3. Rodero L, Mellado E, Rodriguez AC et al. G484S amino acid substitution in lanosterol 14-alpha demethylase (ERG11) is related to fluconazole resistance in a recurrent Cryptococcus neoformans clinical isolate. Antimicrob Agents Chemother 2003; 47: 3653-6.
4. Pfaller MA, Messer SA, Boyken L et al. Global trends in the antifungal susceptibility of Cryptococcus neoformans (1990 to 2004). J Clin Microbiol 2005; 43: 2163-7.
5. Sar B, Monchy D, Vann M et al. Increasing in vitro resistance to fluconazole in Cryptococcus neoformans Cambodian isolates: April 2000 to March 2002. J Antimicrob Chemother 2004; 54: 563-5.
6. Rodriguez-Tudela JL, Barchiesi F, Bille J et al. Method for the determination of minimum inhibitory concentration (MIC) by broth dilution of fermentative yeasts. Clin Microbiol Infect 2003; 9: I-VIII.
7. National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved Standard M27-A2. NCCLS, Wayne, PA, USA, 2002.
8. Rodriguez-Tudela JL, Cuenca-Estrella M, Rodaro L et al. Influence of shaking on antifungal susceptibility testing of Cryptococcus neoformans: a comparison of the NCCLS standard M27A medium, buffered yeast nitrogen base, and RPMI-2% glucose. Antimicrob Agents Chemother 2000; 44: 400-4.
9. Espinel-Ingroff A, Barchiesi F, Cuenca-Estrella M et al. International and multicenter comparison of EUCAST and CLSI M27-A2 broth microdilution methods for testing susceptibilities of Candida spp. to fluconazole, itraconazole, posaconazole, and voriconazole. J Clin Microbiol 2005; 43: 3884-9.
10. Cuenca-Estrella M, Gomez-Lopez A, Mellado E at al. In vitro activities of ravuconazole and four other antifungal agents against fluconazole-resistant or -susceptible clinical yeast isolates. Antimicrob Agents Chemother 2004; 48: 3107-11.
11. Cuenca-Estrella M, Gomez-Lopez A, Mellado E at al. Correlation between the procedure for antifungal susceptibility testing for Candida spp. of the European Committee on Antibiotic Susceptibility Testing (EUCAST) and four commercial techniques. Clin Microbiol Infect 2005; 11: 486-92.
12. Odds FC, De Backer T, Dams G et al. Oxygen as limiting nutrient for growth of Cryptococcus neoformans. J Clin Microbiol 1995; 33: 995-7.
13. Ghannoum MA, Ibrahim AS, Fu Y et al. Susceptibility testing of Cryptococcus neoformans: A microdilution technique. J Clin Microbiol 1992; 30: 2881-6.
14. Jessup CJ, Pfaller MA, Messer SA et al. Fluconazole susceptibility testing of Cryptococcus neoformans: Comparison of two broth microdilution methods and clinical correlates among isolates from Ugandan AIDS patients. J Clin Microbiol 1998; 36: 2874-6.